About
Intrommune Therapeutics develops toothpaste-based oral mucosal immunotherapy products embedding food proteins to desensitize patients with food allergies through daily tooth brushing.
Explore Intrommune Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.